Ionis to Hold First Quarter 2024 Financial Results Webcast
Ionis to Hold First Quarter 2024 Financial Results Webcast
Webcast scheduled for Tuesday, May 7 at 11:30 a.m. Eastern Time
網絡直播定於美國東部時間5月7日星期二上午11點30分進行
CARLSBAD, Calif., April 23, 2024 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that it will host a live webcast on Tuesday, May 7th at 11:30 a.m. Eastern Time to discuss its first quarter 2024 financial results.
加利福尼亞州卡爾斯巴德，2024年4月23日 /PRNewswire/ — 愛奧尼斯製藥公司（納斯達克股票代碼：IONS）今天宣佈，將於5月7日星期二舉辦網絡直播第四 美國東部時間上午11點30分，討論其2024年第一季度的財務業績。
The webcast may be accessed at A replay will be available for a limited time at the same address.
可以在以下地址觀看網絡直播。重播將在有限的時間內在同一地址播出.
About Ionis Pharmaceuticals, Inc.
For three decades, Ionis has invented medicines that bring better futures to people with serious diseases. Ionis currently has five marketed medicines and a leading pipeline in neurology, cardiology, and other areas of high patient need. As the pioneer in RNA-targeted medicines, Ionis continues to drive innovation in RNA therapies in addition to advancing new approaches in gene editing. A deep understanding of disease biology and industry-leading technology propels our work, coupled with a passion and urgency to deliver life-changing advances for patients. To learn more about Ionis visit and follow us on Twitter @ionispharma.
關於 Ionis Pharmicals, Inc
三十年來，愛奧尼斯發明了爲嚴重疾病患者帶來更美好未來的藥物。愛奧尼斯目前有五種上市藥物，並在神經病學、心臟病學和其他患者需求旺盛的領域擁有領先的產品線。作爲RNA靶向藥物的先驅，Ionis除了推進基因編輯的新方法外，還繼續推動RNA療法的創新。對疾病生物學和行業領先技術的深刻理解推動了我們的工作，以及爲患者提供改變生活的進步的熱情和緊迫性。要了解有關 Ionis 的更多信息，請訪問並在 Twitter 上關注我們 @ionispharma。
Ionis Pharmaceuticals Investor Contact:
D. Wade Walke, Ph.D. – [email protected] – 760-603-2331
愛奧尼斯製藥投資者聯繫方式：
D. Wade Walke，博士 — [email protected] — 760-603-2331
Ionis Pharmaceuticals Media Contact:
Hayley Soffer – [email protected] – 760-603-4679
愛奧尼斯製藥媒體聯繫人：
海莉·索弗 — [email protected] — 760-603-4679
SOURCE Ionis Pharmaceuticals, Inc.
來源 Ionis 製藥公司
譯文內容由第三人軟體翻譯。